COX pathway is inhibited by :
**Core Concept**
The cyclooxygenase (COX) pathway is a key enzyme involved in the production of prostanoids, including prostaglandins and thromboxanes, which play a crucial role in inflammation, pain, and fever. COX enzymes exist in two isoforms: COX-1 and COX-2, with COX-1 primarily involved in maintaining gastrointestinal mucosal integrity and COX-2 associated with inflammatory processes.
**Why the Correct Answer is Right**
Aspirin (A), Indomethacin (B), and Diclofenac (C) are all nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit the COX pathway by irreversibly or reversibly binding to the active site of the COX enzymes. Aspirin selectively inhibits COX-1 and COX-2, while Indomethacin and Diclofenac are more selective for COX-2. By inhibiting COX enzymes, these NSAIDs reduce the production of prostanoids, leading to anti-inflammatory, analgesic, and antipyretic effects. This mechanism is essential for their therapeutic use in managing pain, inflammation, and fever.
**Why Each Wrong Option is Incorrect**
**Option A:** Although Aspirin is indeed a COX inhibitor, it's worth noting that its mechanism of action is unique compared to other NSAIDs, as it acetylates and inactivates COX enzymes.
**Option B:** Indomethacin is a COX inhibitor, but it's not the only one; other NSAIDs like Diclofenac also inhibit the COX pathway.
**Option C:** Diclofenac is a COX inhibitor, similar to Aspirin and Indomethacin, but the question asks for all options, not just one.
**Clinical Pearl / High-Yield Fact**
When prescribing NSAIDs, it's essential to be aware of their potential gastrointestinal side effects, which can be attributed to the inhibition of COX-1 and subsequent reduction in prostaglandin production, leading to mucosal damage. This is why patients on long-term NSAID therapy often require gastroprotective agents.
**Correct Answer Line**
β Correct Answer: D. All of these.